DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2021
|
| _version_ | 1797069223187447808 |
|---|---|
| author | Kizhakeyil, A Zaini, NBM Poh, ZS Wong, BHS Loh, X Ng, AS Low, ZS Prasannan, P Gong, C Tan, MGK Nagarajan, C Huang, D Lu, PW Lim, JQ Barrans, S Ong, CK Lim, ST Chng, WJ Follows, G Hodson, DJ Du, MQ Goh, YT Tan, SH Grigoropoulos, NF Verma, NK |
| author_facet | Kizhakeyil, A Zaini, NBM Poh, ZS Wong, BHS Loh, X Ng, AS Low, ZS Prasannan, P Gong, C Tan, MGK Nagarajan, C Huang, D Lu, PW Lim, JQ Barrans, S Ong, CK Lim, ST Chng, WJ Follows, G Hodson, DJ Du, MQ Goh, YT Tan, SH Grigoropoulos, NF Verma, NK |
| author_sort | Kizhakeyil, A |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T22:21:17Z |
| format | Journal article |
| id | oxford-uuid:552430b8-630b-4c33-8cbe-0699d5bafc36 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:21:17Z |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:552430b8-630b-4c33-8cbe-0699d5bafc362022-03-26T16:42:12ZDDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypesJournal articlehttp://purl.org/coar/resource_type/c_545buuid:552430b8-630b-4c33-8cbe-0699d5bafc36EnglishSymplectic ElementsBioMed Central2021Kizhakeyil, AZaini, NBMPoh, ZSWong, BHSLoh, XNg, ASLow, ZSPrasannan, PGong, CTan, MGKNagarajan, CHuang, DLu, PWLim, JQBarrans, SOng, CKLim, STChng, WJFollows, GHodson, DJDu, MQGoh, YTTan, SHGrigoropoulos, NFVerma, NK |
| spellingShingle | Kizhakeyil, A Zaini, NBM Poh, ZS Wong, BHS Loh, X Ng, AS Low, ZS Prasannan, P Gong, C Tan, MGK Nagarajan, C Huang, D Lu, PW Lim, JQ Barrans, S Ong, CK Lim, ST Chng, WJ Follows, G Hodson, DJ Du, MQ Goh, YT Tan, SH Grigoropoulos, NF Verma, NK DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_full | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_fullStr | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_full_unstemmed | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_short | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_sort | ddx3x loss is an adverse prognostic marker in diffuse large b cell lymphoma and is associated with chemoresistance in aggressive non hodgkin lymphoma subtypes |
| work_keys_str_mv | AT kizhakeyila ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT zaininbm ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT pohzs ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT wongbhs ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT lohx ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT ngas ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT lowzs ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT prasannanp ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT gongc ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT tanmgk ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT nagarajanc ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT huangd ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT lupw ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT limjq ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT barranss ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT ongck ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT limst ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT chngwj ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT followsg ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT hodsondj ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT dumq ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT gohyt ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT tansh ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT grigoropoulosnf ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT vermank ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes |